Literature DB >> 8567630

Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity.

H Hasegawa1, M Negishi, A Ichikawa.   

Abstract

We previously identified two isoforms of the mouse prostaglandin E receptor EP3 subtype, EP3 alpha and EP3 beta, with different carboxyl-terminal tails, produced through alternative splicing and showing different efficiency in inhibition of adenylate cyclase (Sugimoto, Y., Negishi, M., Hayashi, Y., Namba, T., Honda, A., Watabe, A., Hirata, M., Narumiya, S., and Ichikawa, A. (1993) J. Biol. Chem. 268, 2712-2718). To assess the role of the carboxyl-terminal tails in the G protein coupling properties of the EP3 receptor, we examined the Gi activities of EP3 alpha, EP3 beta, and the mutant receptor, in which the carboxyl-terminal tail was truncated at the splicing site. The EP3 alpha receptor showed marked agonist-independent constitutive inhibition of adenylate cyclase, while EP3 beta receptor had no agonist-independent inhibition. On the other hand, the truncated receptor showed only agonist-independent constitutive inhibition. The constitutive activity of these receptors on the stimulation of GTPase activity of Gi was also observed. Thus, alternative splicing produced two isoforms with different carboxyl-terminal tails and with different constitutive activity, and the truncation of the carboxyl-terminal tail caused full constitutive activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567630     DOI: 10.1074/jbc.271.4.1857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue.

Authors:  Hu Xu; Jia-Lin Fu; Yi-Fei Miao; Chun-Jiong Wang; Qi-Fei Han; Sha Li; Shi-Zheng Huang; Sheng-Nan Du; Yu-Xiang Qiu; Ji-Chun Yang; Jan-Åke Gustafsson; Richard M Breyer; Feng Zheng; Nan-Ping Wang; Xiao-Yan Zhang; You-Fei Guan
Journal:  J Mol Cell Biol       Date:  2016-07-19       Impact factor: 6.216

Review 2.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

3.  Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.

Authors:  H Grimberg; I Zaltsman; M Lupu-Meiri; M C Gershengorn; Y Oron
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.

Authors:  Andrea Pathe-Neuschäfer-Rube; Frank Neuschäfer-Rube; Gerhard P Püschel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  A Ser/Thr cluster within the C-terminal domain of the rat prostaglandin receptor EP3alpha is essential for agonist-induced phosphorylation, desensitization and internalization.

Authors:  Frank Neuschäfer-Rube; Ricardo Hermosilla; Manuela Kuna; Andrea Pathe-Neuschäfer-Rube; Ralf Schülein; Gerhard Paul Püschel
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

6.  The EP3 Receptor: Exploring a New Target for Type 2 Diabetes Therapeutics.

Authors:  Joshua C Neuman; Michelle E Kimple
Journal:  J Endocrinol Diabetes Obes       Date:  2013 Jul-Sep

7.  Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization.

Authors:  Guo Li; Qi Zhou; Yena Yu; Linjie Chen; Ying Shi; Jiansong Luo; Jeffrey Benovic; Jianxin Lu; Naiming Zhou
Journal:  Mol Pharmacol       Date:  2012-09-07       Impact factor: 4.436

8.  Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo.

Authors:  Ines M Macias-Perez; Roy Zent; Monica Carmosino; Matthew D Breyer; Richard M Breyer; Ambra Pozzi
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

9.  Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Authors:  Jun Li; Xibin Liang; Qian Wang; Richard M Breyer; Louise McCullough; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2008-04-20       Impact factor: 3.046

10.  Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents.

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Mario Duran-Prado; Ana I Pozo-Salas; María M Malagón; F Gracia-Navarro; Rhonda D Kineman; Raul M Luque; Justo P Castaño
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.